Pelthos Therapeutics Inc. Stock Issued During Period, Shares, Restricted Stock Award, Forfeited
Pelthos Therapeutics Inc. (PTHS) reported Stock Issued During Period, Shares, Restricted Stock Award, Forfeited of 1.94 million shares for the 0-month period ending 2024-06-12, per its 10-Q filed 2025-05-13.
Financial Statements › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement
us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited · last filed 2025-05-13
- 2024-06-12: Stock Issued During Period, Shares, Restricted Stock Award, Forfeited 0 month 1.94M shares.
- 2024-04-17: Stock Issued During Period, Shares, Restricted Stock Award, Forfeited 0 month 133.75K shares.
- 2023-04-17: Stock Issued During Period, Shares, Restricted Stock Award, Forfeited 0 month 133.75K shares; Stock Issued During Period, Shares, Restricted Stock Award, Forfeited 0 month as first filed 1.20M shares.
| Period end | Stock Issued During Period, Shares, Restricted Stock Award, Forfeited 0 month | Stock Issued During Period, Shares, Restricted Stock Award, Forfeited 0 month as first filed |
|---|---|---|
| 2024-06-12 | 1.94M shares 10-Q · filed 2025-05-13 | |
| 2024-04-17 | 133.75K shares 10-K · filed 2025-03-27 | |
| 2023-04-17 | 133.75K shares 10-Q · filed 2025-05-13 | 1.20M shares 10-K · filed 2024-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |